"In late 2004, French scientists were given a five-year window for conducting stem cell research. Europe as a whole has also joined in this particular research journey with its Advanced Therapies legislation. Already halfway down the path, it is time to take an objective look at the promises and successes of stem cell research. Top CEOs and scientists will share their expectations as well as their concerns, and they will discuss the success and promise of their own work."

Objective1:Present information about the key assets of the biotech sector in France.

Objective2:Discuss the work and results of stem cell research as scientists try to find applications for such complex illnesses as heart disease, diabetes and Parkinson's.

Objective3:Explain how international collaboration is a must in this uncharted field.